Concepedia

Author

Masaaki Sagara

Dokkyo Medical University

Also Known As

M Sagara, Mariko Sagara, Masaaki Sagara

25

Publications

417

Citations

10

H-Index

22

Concepts

All Affiliations

Dokkyo Medical UniversityDokkyo Medical University Saitama Medical Center
MS

About

Masaaki Sagara is an author at Dokkyo Medical University specializing in medicine, metabolic syndrome, and diabetes.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

76

2

Diabetes

2

2

53

3

Health Sciences

1

1

13

4

Biomedical Engineering

1

1

104

5

Endocrinology

1

1

23

Masaaki Sagara

×

10

Publications

384

Citations

10

H-Index

YearCitations

The effects of early occlusal loading on one-stage titanium alloy implants in beagle dogs: A pilot study

Masaaki Sagara, Yasumasa Akagawa, Hiromasa Nikai,

Journal of Prosthetic Dentistry

1993

104

Clinical Implication of Plasma Hydrogen Sulfide Levels in Japanese Patients with Type 2 Diabetes

Kunihiro Suzuki, Masaaki Sagara, Chie Aoki,

Internal Medicine

2016

75

Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM)

Mihoko Matsumura, Yuki Nakatani, Seiichi Tanka,

Diabetes Therapy

2017

41

Sitagliptin, a DPP-4 inhibitor, alters the subsets of circulating CD4+ T cells in patients with type 2 diabetes

Yoshimasa Aso, Maiko Fukushima, Masaaki Sagara,

Diabetes Research and Clinical Practice

2015

40

Impact of teneligliptin on oxidative stress and endothelial function in type 2 diabetes patients with chronic kidney disease: a case–control study

Masaaki Sagara, Kunihiro Suzuki, Chie Aoki,

Cardiovascular Diabetology

2016

39

Effect of growth hormone replacement therapy on plasma diacron-reactive oxygen metabolites and endothelial function in Japanese patients: The GREAT clinical study

Kunihiro Suzuki, Kazunori Yanagi, Masanori Shimizu,

Endocrine Journal

2017

23

Genetic alteration of ARMC5 in a patient diagnosed with meningioma and primary macronodular adrenal hyperplasia: a case report

Teruo Jojima, Takahiko Kogai, Toshie Iijima,

European Journal of Endocrinology

2020

23

The effects of intermittent use of the SGLT-2 inhibitor, dapagliflozin, in overweight patients with type 2 diabetes in Japan: a randomized, crossover, controlled clinical trial

Kanako Kato, Kunihiro Suzuki, Chie Aoki,

Expert Opinion on Pharmacotherapy

2017

14

Serum levels of soluble dipeptidyl peptidase-4 in type 2 diabetes are associated with severity of liver fibrosis evaluated by transient elastography (FibroScan) and the FAST (FibroScan-AST) score, a novel index of non-alcoholic steatohepatitis with significant fibrosis

Masaaki Sagara, Toshie Iijima, Masato Kase,

Journal of Diabetes and its Complications

2021

13

Serum high-molecular-weight adiponectin and response to dapagliflozin in patients with type 2 diabetes and non-alcoholic fatty liver disease

Yoshimasa Aso, Masaaki Sagara, Takafumi Niitani,

Journal of Investigative Medicine

2021

12

Page 1